A recent Editorial in Nature, ‘Evidence-based medicine: how COVID can drive positive change’ mentions the upcoming Cochrane Convenes event. It explains how the pandemic has spawned too many uninformative clinical trials and reviews and that reform is needed to ensure the world gets the high-quality evidence it needs.
It argues that it is important to assess what worked, what didn’t, and why, and make recommendations for change. It says, “A prime opportunity will arrive in October, at a meeting of global-health leaders organized by Cochrane and the World Health Organization (WHO), as well as other members of a group called COVID-END (COVID-19 Evidence Network to support Decision-making)." "Cochrane and the other organizers of the October meeting say they hope to take any recommendations that emerge to the World Health Assembly in May 2022, to discuss with member states. It’s important for countries to demand — and fund — changes."